Good news for authors of Journal of Theoretical Biology

Dear Dr S. Ruan,

I am pleased to inform you as corresponding author, that your article

, published in 2004.

was one of the top 10 cited papers in 2006* in Journal of Theoretical Biology .

As you may know, Journal of Theoretical Biology is widely accessible by institutes worldwide. Over 4,900 institutions (representing over 9 million researchers) enjoy access to Journal of Theoretical Biology and the journal received nearly 300.000 downloads last year.

May I take this opportunity to thank you for submitting your paper to Journal of Theoretical Biology. I hope the publishing experience was to your satisfaction, and you will consider submitting another manuscript.

We would like to thank and congratulate your co-authors as well. As we do not have their contact information we invite you to forward this email to them.

Sincerely,

Dale Seaton,
Publisher Biology & Parasitoloy

*source: Scopus

Co-Chief Editors:

D. Kirschner
Y. Iwasa
L. Wolpert

View the full Editorial Board

Learn all of the reasons why publishing with Elsevier is a benefit to journal authors

Data Protection Notice:

This e-mail has been sent to ruan@math.miami.edu from Elsevier Ltd., The Boulevard, Langford Lane, Kidlington, Oxford OX5 1GB, registered in England with registered number 1982084, using Email Reaction's technology and platform. To ensure delivery to your inbox (not bulk or junk folders), please add celldevbio@mail.elsevier-alerts.com to your address book or your safe senders list.

You are receiving this e-mail because you are an Author, Editor or Contributor of an Elsevier product in the belief that it will be of interest to you.

If you do not wish to receive general marketing messages from Elsevier Life Science Journals, you can visit this page to , enter your email address, and press the submit button and you will be unsubscribed.

Elsevier respects your privacy and does not disclose, sell or rent your personal information to any non-affiliated third parties without your consent, except as may be stated in the . Please visit this page to see .

For all enquiries, problems or suggestions regarding this service, please contact: .